BPH Energy Limited (ASX:BPH) is pleased to announce its investee Patagonia Genetics has recently acquired an additional 24 CBD and Hemp strains to add to its collection of over 260 strains and to expedite the company's plans to commercialize its genetic library early in 2020.
BPH Energy Limited
The company provides early stage funding, project management and commercialisation strategies for a direct collaboration, a spin out company or to secure a license.
BPH provides funding for commercial strategies for proof of concept, research and product development, whilst the institutional partner provides infrastructure and the core scientific expertise.
BPH currently partners with several academic institutions including The Harry Perkins Institute for Medical Research and Swinburne University of Technology (SUT).
Cortical is an Australian based medical device technology company that has developed an industry disruptive brain function monitor independently described as "a paradigm busting technology from an Australian based device house that really gives a significant advantage in this space".
Advent Energy Ltd is an unlisted oil and gas exploration and development company with onshore and offshore exploration and near-term development assets around Australia.
BPH Energy (BPH or Company) is the second largest shareholder in Advent Energy Ltd (Advent) with a direct interest of 22%.
BPH Energy Limited (ASX:BPH) intends to offer existing eligible shareholders the opportunity to subscribe for up to a maximum of $30,000 of Shares at the offer price of $0.00140056 per Share to raise up to $600,000 under the SPP.
On 21 August 2019 BPH Energy Limited (ASX:BPH) announced that it intended to pursue a complementary strategy of making an investment (or investments) in the medical cannabis sector, as it is considered that an investment of this nature is in line with its investee company strategy and, in particular, its biomedical business.
Cortical Dynamics Ltd has announced its Korean distributor ,Globaluck, has received the KGMP certificate of approval for its BARM (Class II Medical Device) from the Korea Good Manufacturing Practice (KGMP).
BPH Energy Limited (ASX:BPH) is pleased to advise that investee Advent Energy Ltd has been granted a renewal of Retention Licence 1 (RL1) in the Northern Territory by the NT Department of Primary Industry and Resources for a five-year term concluding in July 2023.
BPH Energy Ltd (ASX:BPH) is pleased to provide market update in relation to developments for its Medicinal Cannabis investment Patagonia Genetics.
BPH Energy Ltd (ASX:BPH) wishes to advise that investee Advent Energy Ltd has now terminated by mutual consent the RL Energy Joint Venture Agreement for the PEP11 permit.